Inari Medical, Inc. (NARI)
| Market Cap | 4.02B |
| Revenue (ttm) | 208.18M |
| Net Income (ttm) | 25.02M |
| Shares Out | 49.93M |
| EPS (ttm) | 0.45 |
| PE Ratio | 178.34 |
| Forward PE | 312.50 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,103,174 |
| Open | 81.13 |
| Previous Close | 81.00 |
| Day's Range | 79.89 - 81.34 |
| 52-Week Range | 58.66 - 127.42 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 119.67 (+48.8%) |
| Est. Earnings Date | Nov 11, 2021 |
About NARI
Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.
Financial Performance
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for Inari Medical stock is "Buy." The 12-month stock price forecast is 119.67, which is an increase of 48.79% from the latest price.
News
3 Top Healthcare Stocks You Can Buy for $100 or Less
It doesn't take a lot of upfront cash to add one of these stocks to your portfolio.
American Airlines Group Inc Ranked Among Today's Top Shorts As COVID-19 Concerns Continue To Rise
The Dow rose about 210 points, the S&P 500 rebounded by 0.6%, and the Nasdaq added another 0.6%. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
Why Is Inari Medical, Inc. (NARI) Up 8.8% Since Last Earnings Report?
Inari Medical, Inc. (NARI) reported earnings 30 days ago. What's next for the stock?
3 High-Growth Healthcare Stocks to Buy in September
All three are rapidly expanding into their own corners of America's $4 trillion per year healthcare sector.
3 High-Growth Stocks That Could Soar by 30% or Better According to Wall Street
There's a stock on this list analysts think can climb by around 47%, as soon as more investors come around to their way of seeing things.
Inari Medical to Present at Upcoming Investor Conferences
IRVINE, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...
Wall Street Thinks This Healthcare Stock Could Double Your Money in the Next Year
Even the median estimate would be a 70% gain.
This Healthcare Company Just Shocked Its Investors
The stock price is collapsing as a result.
Inari Medical Plunged 15% After Mixed Q2 Earnings, Lifting FY21 Sales Guidance
Inari Medical Inc's (NASDAQ: NARI) Q2 revenue was $63.5 million, more than doubled from $25.4 million in Q2 FY20, beating the consensus of $59.6 million. The growth was driven by continued U.S. commerci...
Why Shares of Inari Medical Are Falling Today
Dollars outpaced procedures in the second quarter.
Inari Medical (NARI) Q2 Earnings Lag, Revenues Top Estimates
Inari Medical's (NARI) second-quarter 2021 results benefit from significant revenue growth and gross margin expansion.
Inari Medical, Inc. (NARI) Misses Q2 Earnings Estimates
Inari Medical, Inc. (NARI) delivered earnings and revenue surprises of -22.22% and 5.47%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Inari Medical: Q2 Earnings Insights
Shares of Inari Medical (NASDAQ:NARI) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 143.75% year over year to $0.07, which missed ...
Inari Medical Reports Second Quarter 2021 Financial Results
IRVINE, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives o...
3 Things I'm Looking For in Inari Medical's Earnings
What does normal look like?
3 COVID Stocks That Could Soar Higher
Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.
Inari Medical, Inc. (NARI) Earnings Expected to Grow: Should You Buy?
Inari Medical, Inc. (NARI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cinemark Holdings Inc Ranked Among Today's Top Shorts
The Dow Jones gained 94 points, or 0.4%, the S&P 500 added 0.2%, and the Nasdaq rose 0.1%. Find opportunities with today's best short plays from Q.ai's deep learning algorithms.
Inari Medical to Present at the Canaccord Genuity 41st Annual Growth Conference
IRVINE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...
2 Best Buys of the Nasdaq Right Now
The overall market might be expensive, but these stocks aren't.
Inari Medical to Announce Second Quarter 2021 Financial Results
IRVINE, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...
Inari Medical Appoints Outset Medical Executive Rebecca Chambers to Board of Directors
IRVINE, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffer...
Inari Medical Announces Late-Breaking CLOUT Registry Data Demonstrating Long-Term Benefits of Lytic-Free Single-Sessi...
IRVINE, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffer...
Inari's Five Levers of Growth According to the CEO
Flawless execution of management's plan could lead to big gains for the stock in the years ahead.
I'm Buying These 2 Stocks Amid Market Volatility
It's best to keep it simple with high-growth companies that turn a profit.